In a lab in Munich, a transparent mouse glows faintly under the microscope, its nerves and immune cells lit up like constellations in a night sky—each pinpoint of light mapped by an AI named MouseMapper. This isn’t science fiction; it’s the cutting edge of whole-body disease research. Led by Prof. Ali Ertürk at Helmholtz Munich, a team has unveiled a revolutionary tool that’s revealing how obesity doesn’t just pack on pounds—it rewires nerves, disrupts immunity, and damages tissues from face to tail in ways never seen before. And because MouseMapper analyzes entire organisms in 3D, it’s exposing systemic changes that traditional organ-by-organ studies simply miss.
Obesity has long been linked to a cascade of health risks—diabetes, heart disease, stroke, even cancer. But until now, scientists lacked the tools to see how these effects unfold across the entire body at once. MouseMapper changes that. Built on a foundation model, it can automatically segment 31 organs and track nerves and immune cells throughout the body, processing terabytes of imaging data from whole transparent mice. By combining tissue clearing, light-sheet microscopy, and deep learning, the team captured tens of millions of cellular structures in stunning 3D detail—without having to guess where to look.
When the researchers turned MouseMapper on obese mice, the results were startling. The trigeminal nerve—the major facial nerve responsible for sensation and movement—showed dramatic structural loss: fewer endings, fewer branches, less complexity. Behavioral tests confirmed the damage: obese mice responded more slowly to facial touch. But the real breakthrough came when the team examined the trigeminal ganglion, the hub of facial sensory neurons. Using spatial proteomics, they found molecular signs of inflammation and nerve remodeling. Even more striking? The same molecular signature appeared in human trigeminal tissue from people with obesity. “We revealed previously unknown structural and molecular changes in the trigeminal ganglion and its facial branches, and the same molecular signature was conserved in human tissue,” says Dr. Doris Kaltenecker, senior scientist at Helmholtz Munich and first author of the study. “This kind of finding simply cannot emerge from studying one organ at a time.”
The implications go far beyond obesity. MouseMapper offers a new way to study any disease that spans multiple systems—diabetes, cancer, neurodegeneration, autoimmune disorders. For the first time, researchers can see the body not as a collection of isolated parts, but as an interconnected whole. And as this technology evolves, it could help uncover hidden links between diseases, accelerate drug testing, and reveal new therapeutic targets. In a world where chronic illness is on the rise, seeing the full picture might be exactly what medicine needs.